Sonal Sonu/LinkedIn
Feb 14, 2026, 17:18
Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
Sonal Sonu, Transfusion Medicine Specialist, posted on LinkedIn:
“A compatible crossmatch confirms serological compatibility at the time of testing – not absolute transfusion safety.
Evanescent alloantibodies and anamnestic immune responses can still result in delayed hemolytic transfusion reactions.
Safe transfusion is not just about reports.
It requires patient history, clinical context, and vigilance.
Transfusion medicine is clinical judgment – not a checkbox.”
Stay updated with Hemostasis Today.
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque
-
May 22, 2026, 16:25Edward Lee Carter: What Is Changing in Antiplatelet Deprescribing and Why It Matters
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?
-
May 22, 2026, 14:50Eric Topol: New Nature Editorial on the Limits and Promise of AI Scientists
-
May 22, 2026, 14:40Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
-
May 22, 2026, 14:21Clinical Challenges in Thrombosis III – Thrombosis Canada